Clinical Study Connect

Plain-Language Clinical Study and Ingredient Research

Editorial Standards

By ClinicalStudyConnect.com Research Desk | Last updated: September 2026

Our Commitment to Accuracy

Clinical Study Connect provides plain-language summaries and educational explanations of clinical research related to health supplement ingredients. We treat every factual claim as a responsibility. Our editorial standards exist to ensure that what we publish is accurate, transparent, properly sourced, and genuinely useful to readers.

Source Hierarchy

We evaluate and prioritize sources in the following order. Higher-tier sources carry more weight in our reporting:

Tier Source Type How We Use It
1 Systematic reviews and meta-analyses Highest weight — pooled evidence across multiple studies
2 Randomized controlled trials (RCTs) Strong individual evidence when well-designed
3 Observational and cohort studies Supporting evidence with clearly stated design limitations
4 Government health agencies (FDA, NIH, WHO, EFSA) Regulatory context, safety alerts, and approved health claims
5 Professional medical organizations Clinical guidelines and consensus positions
6 In vitro and animal studies Mechanistic context only — clearly labeled as non-human evidence
7 Verified manufacturer data (labels, COAs, official pages) Product-specific facts attributed to the manufacturer
8 Expert commentary from credentialed professionals Contextual perspective, always attributed

We do not treat the following as evidence:

  • Marketing materials, press releases, or advertising copy
  • Unattributed testimonials or user reviews
  • Social media posts or influencer endorsements
  • Manufacturer-funded white papers that have not undergone independent peer review

What We Report and How

Study Summaries

When we summarize a clinical study, every summary includes:

  • The study type (RCT, observational, meta-analysis, etc.)
  • The population studied (age, health status, sample size)
  • The intervention (ingredient, dose, form, duration)
  • The primary outcomes measured
  • The key findings, including effect sizes where reported
  • The study’s stated limitations
  • The funding source, where disclosed

Evidence Assessment

We classify the overall evidence for an ingredient claim using four descriptive levels:

  • Strong — Multiple well-designed human studies with consistent findings
  • Moderate — Some human studies with generally supportive but not fully consistent results
  • Preliminary — Limited human data, early-stage trials, or primarily preclinical evidence
  • Insufficient — Too few studies, conflicting results, or only non-human data available

These classifications reflect our editorial assessment of the available published evidence at the time of writing. They are not FDA determinations and should not be interpreted as medical recommendations.

Separation of Claims

We maintain strict separation between different types of claims:

  • Verified research findings — What peer-reviewed studies actually found, stated with their original qualifiers
  • Manufacturer claims — What a product maker states about their product, clearly attributed as their claim
  • Ingredient-level evidence vs. finished-product evidence — A study on an isolated ingredient does not prove a specific product works; we always note this distinction
  • Traditional use — Historical or cultural use of an ingredient is labeled as traditional use, not clinical evidence
  • Consumer reports — What users report experiencing, clearly identified as anecdotal and not evidence of efficacy
  • Unknowns — What has not been studied, not been reported, or cannot be determined from available evidence

What We Do Not Do

  • We do not provide medical advice, diagnosis, or treatment recommendations
  • We do not claim that any supplement ingredient prevents, treats, or cures any disease
  • We do not fabricate, invent, or embellish research findings
  • We do not cite studies that we have not verified exist in a recognized database
  • We do not present preliminary or animal-only findings as proven human benefits
  • We do not accept payment to feature, promote, or favorably characterize any ingredient or product

Corrections Policy

We take errors seriously. If we discover an inaccuracy in published content — or if a reader, researcher, or other party brings one to our attention — we follow this process:

  1. Verify the reported error against primary sources
  2. Correct the content as quickly as possible
  3. Note the correction with the date and nature of the change at the end of the affected article
  4. Review related content to determine if the same error appears elsewhere

If a study we cited is retracted, corrected, or receives an expression of concern from its publisher, we update our coverage to reflect that change and note the reason.

Review Cycle

Published content is reviewed on a regular schedule:

  • High-interest ingredient pages: reviewed at minimum every 180 days
  • Educational and reference content: reviewed at minimum every 365 days
  • Immediate review triggered by: study retraction, significant new meta-analysis, safety alert from a regulatory agency, or reader-reported error

Each article displays the date it was last reviewed and, where applicable, the date of the next scheduled review.

Editorial Independence

Clinical Study Connect does not accept sponsored content, paid placements, or manufacturer-funded editorial. Our revenue model does not depend on recommending any specific ingredient or product. Our editorial decisions are based solely on the quality, relevance, and recency of available research.

Clinical Study Connect is a property of Marketing By Kevin. For questions about these standards, please visit our Contact page.